369 related articles for article (PubMed ID: 23730823)
1. Role of proton pump inhibitors in the occurrence and the prognosis of spontaneous bacterial peritonitis in cirrhotic patients with ascites.
de Vos M; De Vroey B; Garcia BG; Roy C; Kidd F; Henrion J; Deltenre P
Liver Int; 2013 Oct; 33(9):1316-23. PubMed ID: 23730823
[TBL] [Abstract][Full Text] [Related]
2. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.
Bajaj JS; Zadvornova Y; Heuman DM; Hafeezullah M; Hoffmann RG; Sanyal AJ; Saeian K
Am J Gastroenterol; 2009 May; 104(5):1130-4. PubMed ID: 19337238
[TBL] [Abstract][Full Text] [Related]
3. Proton pump inhibitor use significantly increases the risk of spontaneous bacterial peritonitis in 1965 patients with cirrhosis and ascites: a propensity score matched cohort study.
Min YW; Lim KS; Min BH; Gwak GY; Paik YH; Choi MS; Lee JH; Kim JJ; Koh KC; Paik SW; Yoo BC; Rhee PL
Aliment Pharmacol Ther; 2014 Sep; 40(6):695-704. PubMed ID: 25078671
[TBL] [Abstract][Full Text] [Related]
4. Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression.
Goel GA; Deshpande A; Lopez R; Hall GS; van Duin D; Carey WD
Clin Gastroenterol Hepatol; 2012 Apr; 10(4):422-7. PubMed ID: 22155557
[TBL] [Abstract][Full Text] [Related]
5. Mortality associated with proton pump inhibitors in cirrhotic patients with spontaneous bacterial peritonitis.
Kwon JH; Koh SJ; Kim W; Jung YJ; Kim JW; Kim BG; Lee KL; Im JP; Kim YJ; Kim JS; Yoon JH; Lee HS; Jung HC
J Gastroenterol Hepatol; 2014 Apr; 29(4):775-81. PubMed ID: 24219827
[TBL] [Abstract][Full Text] [Related]
6. Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: a multicenter prospective study.
Terg R; Casciato P; Garbe C; Cartier M; Stieben T; Mendizabal M; Niveyro C; Benavides J; Marino M; Colombato L; Berbara D; Silva M; Salgado P; Barreyro F; Fassio E; Gadano A;
J Hepatol; 2015 May; 62(5):1056-60. PubMed ID: 25481567
[TBL] [Abstract][Full Text] [Related]
7. Association between proton pump inhibitor use and spontaneous bacterial peritonitis in cirrhotic patients with ascites.
Ratelle M; Perreault S; Villeneuve JP; Tremblay L
Can J Gastroenterol Hepatol; 2014 Jun; 28(6):330-4. PubMed ID: 24945188
[TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitor use is associated with spontaneous bacterial peritonitis in patients with liver cirrhosis.
Miura K; Tanaka A; Yamamoto T; Adachi M; Takikawa H
Intern Med; 2014; 53(10):1037-42. PubMed ID: 24827481
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites.
Dam G; Vilstrup H; Watson H; Jepsen P
Hepatology; 2016 Oct; 64(4):1265-72. PubMed ID: 27474889
[TBL] [Abstract][Full Text] [Related]
10. Association between acid suppressive therapy and spontaneous bacterial peritonitis in cirrhotic patients with ascites.
Choi EJ; Lee HJ; Kim KO; Lee SH; Eun JR; Jang BI; Kim TN
Scand J Gastroenterol; 2011 May; 46(5):616-20. PubMed ID: 21275825
[TBL] [Abstract][Full Text] [Related]
11. Proton pump inhibitors do not increase the risk for recurrent spontaneous bacterial peritonitis in patients with cirrhosis.
Kim JH; Lim KS; Min YW; Lee H; Min BH; Rhee PL; Kim JJ; Koh KC; Paik SW
J Gastroenterol Hepatol; 2017 May; 32(5):1064-1070. PubMed ID: 28449345
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites.
Mandorfer M; Bota S; Schwabl P; Bucsics T; Pfisterer N; Summereder C; Hagmann M; Blacky A; Ferlitsch A; Sieghart W; Trauner M; Peck-Radosavljevic M; Reiberger T
PLoS One; 2014; 9(11):e110503. PubMed ID: 25369194
[TBL] [Abstract][Full Text] [Related]
13. Role of proton pump inhibitors in the occurrence of spontaneous bacterial peritonitis.
Chitsaz E
Liver Int; 2014 Apr; 34(4):645. PubMed ID: 24325464
[No Abstract] [Full Text] [Related]
14. The Negative Prognostic Impact of a First Ever Episode of Spontaneous Bacterial Peritonitis in Cirrhosis and Ascites.
Ra G; Tsien C; Renner EL; Wong FS
J Clin Gastroenterol; 2015; 49(10):858-65. PubMed ID: 25811112
[TBL] [Abstract][Full Text] [Related]
15. Acid-suppressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis.
Deshpande A; Pasupuleti V; Thota P; Pant C; Mapara S; Hassan S; Rolston DD; Sferra TJ; Hernandez AV
J Gastroenterol Hepatol; 2013 Feb; 28(2):235-42. PubMed ID: 23190338
[TBL] [Abstract][Full Text] [Related]
16. Response to the letter of Chitsaz et al. 'the role of proton pump inhibitors in the occurrence of spontaneous bacterial peritonitis'.
de Vos M; Henrion J; Deltenre P
Liver Int; 2014 Jul; 34(6):964-5. PubMed ID: 24423247
[No Abstract] [Full Text] [Related]
17. Bacterial infections in cirrhosis: role of proton pump inhibitors and intestinal permeability.
van Vlerken LG; Huisman EJ; van Hoek B; Renooij W; de Rooij FW; Siersema PD; van Erpecum KJ
Eur J Clin Invest; 2012 Jul; 42(7):760-7. PubMed ID: 22288900
[TBL] [Abstract][Full Text] [Related]
18. Association Between Proton Pump Inhibitor Therapy and Spontaneous Bacterial Peritonitis Occurrence in Cirrhotic Patients: A Clinical Review.
Zhang M; Liu W; Xu X; Chen T; Qi JY
Curr Med Sci; 2022 Aug; 42(4):673-680. PubMed ID: 35870102
[TBL] [Abstract][Full Text] [Related]
19. Proton Pump Inhibitors Use and Increased Risk of Spontaneous Bacterial Peritonitis in Cirrhotic Patients: A Retrospective Cohort Analysis.
Dahabra L; Kreidieh M; Abureesh M; Abou Yassine A; Deeb L
Gastroenterology Res; 2022 Aug; 15(4):180-187. PubMed ID: 36128183
[TBL] [Abstract][Full Text] [Related]
20. Intestinal permeability in cirrhotic patients with and without spontaneous bacterial peritonitis: is the ring closed?
Scarpellini E; Valenza V; Gabrielli M; Lauritano EC; Perotti G; Merra G; Dal Lago A; Ojetti V; Ainora ME; Santoro M; Ghirlanda G; Gasbarrini A
Am J Gastroenterol; 2010 Feb; 105(2):323-7. PubMed ID: 19844200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
